Doctronic logo spinning Doctronic logo spinning
Skipping wait room...
Accessing the latest medicine...
Starting secure consult...

Mesalamine: The Go-To Drug for Ulcerative Colitis?

Published: May 07, 2024

Mesalamine is a common treatment for ulcerative colitis, but how does it work? Discover how this drug can help manage UC symptoms.
Contents

What is Mesalamine?

Mesalamine is a medication used to treat inflammation in ulcerative colitis. It works by reducing the inflammation in the lining of the colon, helping to relieve symptoms like diarrhea and rectal bleeding. Available in oral and topical forms, it's often the first choice for mild to moderate UC.

How Effective is Mesalamine?

Studies have shown that mesalamine is effective in inducing remission in UC. Patients using mesalamine often experience a reduction in symptoms within a few weeks. Its efficacy can vary based on the dosage and form used, with topical treatments generally being preferred for localized symptoms.
Mesalamine is a medication used to treat inflammation in ulcerative colitis by reducing inflammation in the colon lining, alleviating symptoms such as diarrhea and rectal bleeding.

Potential Side Effects

While mesalamine is generally safe, some patients may experience side effects such as headaches, nausea, or abdominal pain. It's important to discuss any concerns with a healthcare provider. Regular monitoring can help manage any adverse effects and ensure the treatment is working effectively.

Frequently Asked Questions

It's used to treat inflammation in ulcerative colitis.

It can be taken orally or used as a topical treatment.

Yes, it is effective in inducing remission for many patients.

Headaches, nausea, and abdominal pain are possible side effects.

Final Prescription

Could mesalamine be the key to managing your UC symptoms effectively?
Consult with Doctronic to see if mesalamine is right for you!

Related Articles

References

  1. Singh S, Feuerstein JD, Binion DG, Tremaine WJ. AGA Technical Review on the Management of Mild-to-Moderate Ulcerative Colitis. Gastroenterology 2019; 156:769.
  2. Marshall JK, Thabane M, Steinhart AH, et al. Rectal 5-aminosalicylic acid for induction of remission in ulcerative colitis. Cochrane Database Syst Rev 2010; :CD004115.

This article has been reviewed for accuracy by one of the licensed medical doctors working for Doctronic. Always discuss health information with your healthcare provider.

AI Doctor Visit Required

Appointments available 24/7

😀 😀 😀
stethoscope

Top licensed doctors

Available in all 50 states

dossier

Full service care

Prescriptions, referrals & treatment

check

No insurance needed

All notes available in Doctronic

15-min consultation. No hidden costs.

AI Doctor Visit Required
Close icon

Please Chat With Our AI Doctor First

Our AI doctor assessment helps our human doctors prepare for your video visit and provide better care

Lifebuoy

For safety reasons we have been forced to end this consultation.

If you believe this is a medical emergency please call 911 or your local emergency services immediately.

If you are experiencing emotional distress, please call the the Suicide & Crisis Lifeline at 988 or your local crisis services immediately.

Contact us

You can also email us at help@doctronic.ai

We aim to reply within 5-7 days

How likely are you to recommend Doctronic to friends or family?
Not likely at all Extremely likely